FDA OKs New Keytruda Shot for Cancer
The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars. Read more
Read More
‘Tax the Rich,’ French Protesters Cry, as the Wealthy Push Back on Paying More
With a budget crisis looming, a proposal for a tax on ultrahigh-wealth individuals has grass-roots support, but it adds conflict to an already fragmented political landscape. Read more
Read More
U.S. Sues Ticketmaster Over Claims of Illegal Resale Tactics
The Federal Trade Commission and seven states sued Ticketmaster and its parent company, Live Nation, claiming they misled artists and consumers. Read more
Read More